View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Douglas Lindahl
  • Douglas Lindahl

Trelleborg (Hold, TP: SEK425.00) - Muted end to the year

We estimate Q4 sales of SEK8,628m, organic growth of c-1% YOY and adj. EBITA of SEK1,498m (2% above consensus). We expect a neutral outlook from management going into 2025, and have increased our 2024–2026e adj. EBIT by c2% on average (mainly due to FX). We reiterate our HOLD, but have raised our target price to SEK425 (400) on updated valuation and estimates. Trelleborg’s valuation premium relative to its Swedish Capital Goods peer group has increased recently, in our view leaving limited furth...

Trelleborg AB: 1 director

A director at Trelleborg AB bought 5,000 shares at 363.980SEK and the significance rating of the trade was 77/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

Douglas Lindahl
  • Douglas Lindahl

Trelleborg (Hold, TP: SEK400.00) - Lacklustre demand environment

The Q3 results were somewhat below expectations (adj. EBIT c4% below consensus), although the Medical Solutions business showed margin strength through the Baron Group acquisition. We see an overall weaker demand environment ahead. We have cut our 2024–2026e adj. EBIT by 6% on average, and lowered our target price to SEK400 (430), but reiterate our HOLD.

ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
ABGSC Capital Goods Research ... (+5)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
  • Lara Mohtadi
  • Olof Cederholm

The Capital Goods Data Miner - August 2024

Our key long ideas are: Alfa Laval, Hexagon, Metso, Sandvik, Volvo. We are cautious on: Autoliv, Nibe, Wärtsilä

Douglas Lindahl
  • Douglas Lindahl

Trelleborg (Hold, TP: SEK430.00) - Recognition reflected in valuation

Trelleborg’s more optimistic outlook comment for Q3 was quite expected, but the growth of the Medical business stood out to us. Nevertheless, we have left our adj. EBITA estimates for 2024–2026 essentially unchanged, and reiterate our SEK430 target price and HOLD. We have historically posited for expanding multiples for Trelleborg, while we now see this gap as being nearly filled.

ABGSC Capital Goods Research ... (+4)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
  • Olof Cederholm

Higher demand guidance

Q2'24 in line with expectations. Guides for slightly higher demand in Q3, above expectations. We raise '24-'25e adj. EBITA by 2%, keep HOLD.

ABGSC Capital Goods Research ... (+4)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
  • Olof Cederholm
ABGSC Capital Goods Research ... (+4)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
  • Olof Cederholm

Q2e: Pace of recovery in question

Orders, sales and earnings flat in Q2e and '24e. Stalling PMIs = '25e recovery risk, sector could flatline. Autoliv up to HOLD, Munters up to BUY; prefer Alfa, Metso, Sandvik.

ABGSC Capital Goods Research ... (+4)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
  • Olof Cederholm

Buy-backs supporting the stock

Q2'24 report due on 18 July. Steady performance, limited estimate changes. Keep HOLD and SEK 375 TP.

Douglas Lindahl
  • Douglas Lindahl

Trelleborg (Hold, TP: SEK430.00) - Back in (organic) growth mode soon

We estimate Q2 sales of SEK8,677m, organic growth of c0% YOY, and adj. EBITA of SEK1,620m (3% above consensus). We expect a somewhat raised outlook from management as we enter H2, and we have increased our 2024–2026e adj. EBIT by c1% on average. We reiterate our HOLD, but have raised our target price to SEK430 (395) on updated valuation and estimates.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch